Slingshot members are tracking this event:
FDA Approves Design for Global Blood's (GBT) Phase 3 Hope Trial Evaluating GBT440 in Sickle Cell Disease
Slingshot Insights Explained
Oct 24, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Fda, Phase 3, Hope Trial, Gbt440, Design Approval, Sickle Cell Disease